Luckwel Pharmaceuticals Inc. Stock price




Investment Holding Companies

Delayed OTC Markets 10:13:51 2021-10-13 am EDT Intraday chart for Luckwel Pharmaceuticals Inc. 5-day change 1st Jan Change
3.5 USD +75.00% -.--% -.--%
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 48 2013
Members of the board TitleAgeSince
Chief Executive Officer 48 2013
More insiders
Luckwel Pharmaceuticals Inc. creates medicine to cure diseases. The Company is focused on autoimmune disease, human immunodeficiency virus (HIV) / acquired immune deficiency syndrome (AIDS) and infectious diseases. The Company’s pipelines include LWEL-2120 for the treatment of rheumatoid arthritis (RA), LWEL-2119 for the treatment of HIV and LWEL-2103 for the treatment of COVID-19.
More about the company
  1. Stock
  2. Equities
  3. Stock Luckwel Pharmaceuticals Inc. - OTC Markets
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration